Zinc supplementation in young children with acute diarrhea in India

BACKGROUND: In developing countries the duration and severity of diarrheal illnesses are greatest among infants and young children with malnutrition and impaired immune status, both factors that may be associated with zinc deficiency. In children with severe zinc deficiency, diarrhea is common and responds quickly to zinc supplementation.

METHODS: To evaluate the effects of daily supplementation with 20 mg of elemental zinc on the duration and severity of acute diarrhea, we conducted a double-blind, randomized, controlled trial involving 937 children, 6 to 35 months of age, in New Delhi, India. All the children also received oral rehydration therapy and vitamin supplements.

RESULTS: Among the children who received zinc supplementation, there was a 23 percent reduction (95 percent confidence interval, 12 percent to 32 percent) in the risk of continued diarrhea. Estimates of the likelihood of recovery according to the day of zinc supplementation revealed a reduction of 7 percent (95 percent confidence interval, -9 percent to +22 percent) in the risk of continued diarrhea during days 1 through 3 and a reduction of 38 percent (95 percent confidence interval, 27 percent to 48 percent) after day 3. When zinc supplementation was initiated within three days of the onset of diarrhea, there was a 39 percent reduction (95 percent confidence interval, 7 percent to 61 percent) in the proportion of episodes lasting more than seven days. In the zinc-supplementation group there was a decrease of 39 percent (95 percent confidence interval, 6 percent to 70 percent) in the mean number of watery stools per day (P = 0.02) and a decrease of 21 percent (95 percent confidence interval, 10 percent to 31 percent) in the number of days with watery diarrhea. The reductions in the duration and severity of diarrhea were greater in children with stunted growth than in those with normal growth.

CONCLUSION: For infants and young children with acute diarrhea, zinc supplementation results in clinically important reductions in the duration and severity of diarrhea.

Errataetall:

CommentIn: N Engl J Med. 1995 Sep 28;333(13):873-4. - PMID 7651481

Medienart:

Artikel

Erscheinungsjahr:

1995

Erschienen:

1995

Enthalten in:

Zur Gesamtaufnahme - volume:333

Enthalten in:

The New England journal of medicine - 333(1995), 13 vom: 28. Sept., Seite 839-44

Sprache:

Englisch

Beteiligte Personen:

Sazawal, S [VerfasserIn]
Black, R E [VerfasserIn]
Bhan, M K [VerfasserIn]
Bhandari, N [VerfasserIn]
Sinha, A [VerfasserIn]
Jalla, S [VerfasserIn]

Themen:

Age Factors
Asia
Child
Clinical Trial
Demographic Factors
Developing Countries
Diarrhea
Diseases
Double-blind Studies
India
Ingredients And Chemicals
Inorganic Chemicals
J41CSQ7QDS
Journal Article
Metals
Population
Population Characteristics
Randomized Controlled Trial
Research Methodology
Research Report
Research Support, Non-U.S. Gov't
Southern Asia
Studies
Treatment
Youth
Zinc
Zinc--administraction and dosage
Zinc--therapeutic use

Anmerkungen:

Date Completed 28.09.1995

Date Revised 27.08.2022

published: Print

CommentIn: N Engl J Med. 1995 Sep 28;333(13):873-4. - PMID 7651481

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM076274616